Answers are grounded in this paper and cite their sources.
The designing of an ROA can be challenging and can lead to exaggerated pharmacology if not accurately developed, optimized, and validated. However, improvements in our understanding of epitopes, binding, affinities, and pharmacological effects may lead to improved antibody drug targeting and receptor evaluation.
No takes yet. Share an insight, caveat, or question.
Audia et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: